Wednesday 16 July 2014          13:30 – 15:00
Track 2 - Phosphodiesterase 4 inhibitors as novel anti-inflammatory drugs

Chair: Eeva Moilanen & Heikki Vapaatalo

Phosphodiesterase 4 inhibitors as anti-inflammatory drugs
Heikki Vapaatalo

Phosphodiesterase inhibitors as novel treatments for asthma and COPD
Domenico Spina

PDE4 inhibitors in the treatment of arthritis and psoriasis
Georg Schett

Anti-inflammatory mechanisms of PDE4 inhibitors: role of MAP kinase phosphatase-1
Eeva Moilanen

South African Society for Basic and Clinical Pharmacology Section 21 Company, Registration no. 2006/029963/08 Registry Office: Alchemy Financial Services Unit 3 Bush Hill Office Park, Jan Frederick Ave, Honeydew 2154

© Scatterlings Conference and Events